Back to Search
KELSEY LACKEY, PHARMD
PHARMD
Pharmacist
NPI: 1386086585Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
R-15309(OK)
Research & Publications (20)
Correspondence of perceived vs. objective proximity to parks and their relationship to park-based physical activity.
PMID 19671173·Int J Behav Nutr Phys Act·2009
8-other
Knowledge-based design of 7-azaindoles as selective B-Raf inhibitors.
PMID 18662874·Bioorg Med Chem Lett·2008
8-other
The discovery of substituted 4-(3-hydroxyanilino)-quinolines as potent RET kinase inhibitors.
PMID 17884497·Bioorg Med Chem Lett·2007
8-other
Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series.
PMID 16777410·Bioorg Med Chem Lett·2006
8-other
Aza-stilbenes as potent and selective c-RAF inhibitors.
PMID 16890436·Bioorg Med Chem Lett·2006
8-other
Lessons from the drug discovery of lapatinib, a dual ErbB1/2 tyrosine kinase inhibitor.
PMID 16719802·Curr Top Med Chem·2006
6-review
Protection from interferon-induced apoptosis by Epstein-Barr virus small RNAs is not mediated by inhibition of PKR.
PMID 16282456·J Virol·2005
8-other
Discovery and in vitro evaluation of potent kinase inhibitors: Pyrido[1',2':1,5]pyrazolo[3,4-d]pyrimidines.
PMID 15993060·Bioorg Med Chem Lett·2005
8-other
Discovery and in vitro evaluation of potent TrkA kinase inhibitors: oxindole and aza-oxindoles.
PMID 15013000·Bioorg Med Chem Lett·2004
8-other
A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells.
PMID 15374980·Cancer Res·2004
8-other
Medicinal chemistry--29th National Symposium. Kinase inhibitors.
PMID 15334305·IDrugs·2004
7-preclinical
Medicinal chemistry--29th National Symposium. SERMs and SARMs.
PMID 15334304·IDrugs·2004
7-preclinical
Synthesis and SAR of potent EGFR/erbB2 dual inhibitors.
PMID 14684309·Bioorg Med Chem Lett·2004
8-other
Expression of 1L-myoinositol-1-phosphate synthase in organelles.
PMID 12913178·Plant Physiol·2003
8-other
Discovery and biological evaluation of potent dual ErbB-2/EGFR tyrosine kinase inhibitors: 6-thiazolylquinazolines.
PMID 12639547·Bioorg Med Chem Lett·2003
7-preclinical
Comparison of the biochemical and kinetic properties of the type 1 receptor tyrosine kinase intracellular domains. Demonstration of differential sensitivity to kinase inhibitors.
PMID 11696537·J Biol Chem·2002
4-observational
Small molecule inhibitors of the class 1 receptor tyrosine kinase family.
PMID 12171567·Curr Top Med Chem·2002
6-review
A prodrug approach to the design of cRaf1 kinase inhibitors with improved cellular activity.
PMID 11762640·Anticancer Drug Des·2001
8-other
The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo.
PMID 12467226·Mol Cancer Ther·2001
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4502 E 41ST ST, SUITE 2H23
TULSA, OK 74135 - Phone
- (918) 660-3018
Quick Facts
- NPI
- 1386086585
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile